Today’s top gainers include the company GlaxoSmithKline plc (NYSE:GSK) which is in the industry Drug Manufacturers – Major, gaining -0.50% today. In the last week its performance is -0.41%, and 6.71% for the past quarter. Currently, GlaxoSmithKline plc, GSK has a target price of 48.67, so today’s gain of -0.50% is a significant step towards its target price. The GAP today is therefore 0.14%.
GlaxoSmithKline plc (NYSE:GSK), has a market cap of 107845.5, and is based in United Kingdom. Insider ownership is at 0.20%, and institutional ownership is 8.90%.
At the current price of 44.17, it has a dividend yield of 4.96%, and its target price is 48.67. This is with a profit margin of 0.10%, and total debt/equity of 34.12. GlaxoSmithKline plc (NYSE:GSK) has a P/E of 3170.71, as well as a forward P/E of 16.11.
With a current EPS of 0.01, and a forecasted EPS growth for next year at 5.72%,GlaxoSmithKline plc (NYSE:GSK) has had a EPS growth for the past five years at 40.20%. For the next five years EPS growth is projected to be 10.00%.
Performance for the year is 8.01%. Since its IPO date on 7/9/1986, the total performance to date is 16.31%.
Volume today for GlaxoSmithKline plc (NYSE:GSK), is 2349766, while its average volume is 3392.04. Whilst the total gain today was -0.50%, it did have a day high of -1.99%.
Volatility for this week has been at 0.84%, and 0.91% for the month. The 52-week low for GlaxoSmithKline plc, GSK has been 27.18%, while the 52-week-high has reached -1.99%.
Looking at its return of investments, which is 41.40%, and its return on assets is 0.10%. GlaxoSmithKline plc (NYSE:GSK) has an operating margin of 5.30%. With a sales growth of 10.90% quarter over quarter. Bearing in mind that GlaxoSmithKline plc, GSK is in the sector Healthcare, its long-term debt/equity is 26.3, and has a current ratio of 0.9 and 0.6 for quick ratio.
So what is the value of GlaxoSmithKline plc? Well its PEG is 317.07, and the P/S is 3.21, along with a P/B of 138.72. Meanwhile it has a p/cash of 17.28.